Bruce Milne Hall

Title: Bruce Milne Hall: Innovator in Immunology

Introduction

Bruce Milne Hall is a notable inventor based in Strathfield, Australia. He has made significant contributions to the field of immunology, particularly in the study of T cells. With a total of 4 patents to his name, Hall's work has advanced our understanding of immune responses.

Latest Patents

One of Hall's latest patents is titled "Cd4+ Cd25+ T-cells activated to a specific antigen." This invention relates to a method of assessing whether a subject comprises CD4+, CD25+ T cells that have been activated to a specific antigen. The method involves obtaining a sample of lymphocytes from the subject, incubating the sample to distinguish activated T cells, and determining their presence. Additionally, Hall has developed methods for growing these activated T cells in vitro and increasing tolerance in subjects using these cells. Another significant patent focuses on identifying CD4CD25T cells activated to an antigen in a population of T cells, which includes isolating these cells and administering them to increase tolerance to an antigen.

Career Highlights

Throughout his career, Bruce Milne Hall has worked with prominent organizations, including Newsouth Innovations Pty Limited and Novartis AG. His experience in these companies has allowed him to collaborate on various innovative projects that have contributed to advancements in medical science.

Collaborations

Hall has collaborated with notable colleagues such as Suzanne Jean Hodgkinson and Gregorio Aversa. These partnerships have further enriched his research and development efforts in the field of immunology.

Conclusion

Bruce Milne Hall's contributions to immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the understanding and treatment of immune-related conditions.